- Valves
- Delivery System
Transcatheter Pulmonary Valve (TPV) Therapy Market size was valued at USD 37.8 million in 2022 and is expected to reach USD 66.4 million 2029, at a CAGR of 7.2% from 2023-2029. Transcatheter pulmonary valve replacement is a surgical procedure carried in older children and adults with congenital heart disease and have normally at least one previous operation. These valves are delivery by hollow, thin, and long tube system that delivers the transcatheter pulmonary valve into hear without open heart surgery. The Transcatheter Pulmonary Valve (TPV) is a synthetic heart valve created from a cow's jugular vein valve sewed onto a tiny metal frame. Transcatheter pulmonary valves are delivered through a catheter, which is a thin, hollow, and lengthy tube that is inserted into the heart without the need for open heart surgery while the heart is beating. The transcatheter pulmonary valve is first compressed onto a balloon at the tip of the delivery catheter to deliver into the body, then the balloon in the pulmonary heart valve is inflated to open up the transcatheter pulmonary valve and the catheter is removed from the body, after which it becomes the new pulmonary heart valve. Patients with heart abnormalities who have a failing conduit may benefit from a transcatheter pulmonary valve. The transcatheter pulmonary valve allows patients to postpone the need for additional open heart surgery. Transcatheter Pulmonary Valve (TPV) Therapy Market is being pushed by an increase in the prevalence of comorbidities such as diabetes and cardiovascular illnesses, as well as an increase in the incidence of Congestive Heart Diseases (CHD) among patients of various ages. Transcatheter pulmonary valves are used to extend the functional life of RV-PA conduits, restore pulmonary valve competence, and relieve conduit stenosis in patients without causing regurgitation, making the transcatheter pulmonary valve market profitable over the projected period.
Transcatheter Pulmonary Valve Tpv Therapy Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
X%
Largest Market
North America
Fastest Growing Market
Europe
Transcatheter Pulmonary Valve (TPV) Therapy Market Dynamics
Increase in the prevalence of congenital heart diseases is a key factor drive the growth of global transcatheter pulmonary valve therapy market. Moreover, prolonged effectiveness of transcatheter valves, increase in the R&D for the innovation of newer products, and change in lifestyle leads to increase in prevalence of cardiovascular diseases are anticipated to fuel the transcatheter pulmonary valve (TPV) therapy market over the forecast period. However, stringent regulatory guidelines, low target population, high cost of therapy, and lack of skilled professionals may restrain the growth of transcatheter pulmonary valve (TPV) therapy market.
North-America got significant share
Transcatheter Pulmonary Valve (TPV) Therapy Market
Geographically, global transcatheter pulmonary valve (TPV) therapy market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa regions. North America transcatheter pulmonary valve therapy market growth driven by rise in the prevalence of cardiovascular diseases, rise in R&D for the innovation of newer products, and increase in healthcare expenditure. Europe transcatheter pulmonary valve therapy market has a lucrative growth owing high adoption of newer devices, sophisticated healthcare infrastructure, and increase in the prevalence of cardiovascular diseases due to change in lifestyle are boost the market. Asia Pacific transcatheter pulmonary valve therapy market has a significant share, which is attributed to large patient population, development in R&D for the innovation of newer products, and development on healthcare infrastructure are propel the market. Latin America transcatheter pulmonary valve therapy market expected to present notable growth due to expansion of business by the companies and development in economic growth are fuel the market.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Transcatheter Pulmonary Valve Tpv Therapy Market Segmentation
By Product Type
By End User
- Hospitals
- Cardiology Clinics
- Ambulatory Surgical Centers
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Frequently Asked Questions
The Transcatheter Pulmonary Valve (TPV) Therapy Market is growing at a CAGR of 7.2% over the Forecast Period
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
| 1.Executive Summary |
| 2.Global Transcatheter Pulmonary Valve (TPV) Therapy Market Introduction |
| 2.1.Global Transcatheter Pulmonary Valve (TPV) Therapy Market - Taxonomy |
| 2.2.Global Transcatheter Pulmonary Valve (TPV) Therapy Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.End Users |
| 2.2.3.Region |
| 3.Global Transcatheter Pulmonary Valve (TPV) Therapy Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Transcatheter Pulmonary Valve (TPV) Therapy Market Analysis, 2018-2022 and Forecast 2023-2029 |
| 4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Transcatheter Pulmonary Valve (TPV) Therapy Market By Product Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 5.1. Valves |
| 5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Delivery System |
| 5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Transcatheter Pulmonary Valve (TPV) Therapy Market By End Users, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 6.1. Hospital Pharmacies |
| 6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Cardiology Clinics |
| 6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Ambulatory Surgical Centers |
| 6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Transcatheter Pulmonary Valve (TPV) Therapy Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Transcatheter Pulmonary Valve (TPV) Therapy Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 8.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Valves |
| 8.1.2.Delivery System |
| 8.2. End Users Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Hospital Pharmacies |
| 8.2.2.Cardiology Clinics |
| 8.2.3.Ambulatory Surgical Centers |
| 8.3. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Transcatheter Pulmonary Valve (TPV) Therapy Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 9.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Valves |
| 9.1.2.Delivery System |
| 9.2. End Users Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Hospital Pharmacies |
| 9.2.2.Cardiology Clinics |
| 9.2.3.Ambulatory Surgical Centers |
| 9.3. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 9.3.6.Rest of EU |
| 10.Asia Pacific (APAC) Transcatheter Pulmonary Valve (TPV) Therapy Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Valves |
| 10.1.2.Delivery System |
| 10.2. End Users Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Hospital Pharmacies |
| 10.2.2.Cardiology Clinics |
| 10.2.3.Ambulatory Surgical Centers |
| 10.3. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Transcatheter Pulmonary Valve (TPV) Therapy Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Valves |
| 11.1.2.Delivery System |
| 11.2. End Users Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Hospital Pharmacies |
| 11.2.2.Cardiology Clinics |
| 11.2.3.Ambulatory Surgical Centers |
| 11.3. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Transcatheter Pulmonary Valve (TPV) Therapy Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Valves |
| 12.1.2.Delivery System |
| 12.2. End Users Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Hospital Pharmacies |
| 12.2.2.Cardiology Clinics |
| 12.2.3.Ambulatory Surgical Centers |
| 12.3. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Venus MedTech (China) |
| 13.2.2.Inova (U.S.) |
| 13.2.3.Edward Lifesciences (U.S.) |
| 13.2.4.Medtronic Plc. (Ireland) |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
- Venus MedTech (China)
- Inova (U.S.)
- Edward Lifesciences (U.S.)
- Medtronic Plc. (Ireland)